BANK VONTOBEL/CALL/PFIZER INC/32/0.1/20.12.24 Share Price

Warrant

DE000VM7SEJ8

Real-time Boerse Frankfurt Warrants 05:31:04 04/07/2024 pm IST
0.056 EUR +9.80% Intraday chart for BANK VONTOBEL/CALL/PFIZER INC/32/0.1/20.12.24
Current month-13.56%
1 month-54.05%
Date Price Change
04/24/04 0.056 +9.80%
03/24/03 0.051 -5.56%
02/24/02 0.054 -18.18%
01/24/01 0.066 +11.86%
28/24/28 0.059 +3.51%

Real-time Boerse Frankfurt Warrants

Last update July 04, 2024 at 05:31 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM7SEJ
ISINDE000VM7SEJ8
Date issued 02/01/2024
Strike 32 $
Maturity 20/12/2024 (169 Days)
Parity 10 : 1
Emission price 0.18
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.233
Lowest since issue 0.041
Delta0.24x
Omega 9.904
Premium17.9x
Gearing42.06x
Moneyness 0.8656
Difference Strike 4.3 $
Difference Strike %+13.44%
Spread 0.01
Spread %15.15%
Theoretical value 0.0600
Implied Volatility 27.32 %
Total Loss Probability 81.54 %
Intrinsic value 0.000000
Present value 0.0600
Break even 32.65 €
Theta-0x
Vega0.01x
Rho0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7 USD
Average target price
31.92 USD
Spread / Average Target
+15.22%
Consensus